Cheng Jiang

Zhejiang Provincial Key Laboratory Of Traditional Chinese Medicine For Pharmacodynamic Material Basis Research Of Chinese Medicine
Hangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Potential heterogeneity of epcoritamab associated adverse events in demographics and dosing regimens.

Potential heterogeneity of epcoritamab associated adverse events in demographics and dosing regimens.

Journal: Frontiers in medicine

Published: March 17, 2026

Extracellular Matrix Stiffness as a Key Molecular Event in Early Osteoarthritis: Crosstalk Between the RhoA/ROCK and ERK1/2 Pathways.

Extracellular Matrix Stiffness as a Key Molecular Event in Early Osteoarthritis: Crosstalk Between the RhoA/ROCK and ERK1/2 Pathways.

Journal: The American journal of sports medicine

Published: February 19, 2026

Comprehensive analysis of cefuroxime-associated adverse events: Insights from JADER database (2004-2024) and comparison with FAERS database.

Comprehensive analysis of cefuroxime-associated adverse events: Insights from JADER database (2004-2024) and comparison with FAERS database.

Journal: Medicine

Published: December 04, 2025

N6-Methyladenosine Demethylase FTO Mitigates Cerebral Ischemia-Reperfusion Injury by Suppressing AQP4 Expression.

N6-Methyladenosine Demethylase FTO Mitigates Cerebral Ischemia-Reperfusion Injury by Suppressing AQP4 Expression.

Journal: CNS neuroscience & therapeutics

Published: October 17, 2025

Therapeutic potential of dehydroepiandrosterone in early osteoarthritis: Modulating cartilage ECM stiffness through LOX-RhoA/ROCK/MLC signalling - An in vivo study.

Therapeutic potential of dehydroepiandrosterone in early osteoarthritis: Modulating cartilage ECM stiffness through LOX-RhoA/ROCK/MLC signalling - An in vivo study.

Journal: The Journal of steroid biochemistry and molecular biology

Published: October 08, 2025

Exploration of adverse event profiles for glofitamab: A disproportionality analysis using the FDA adverse event reporting system.

Exploration of adverse event profiles for glofitamab: A disproportionality analysis using the FDA adverse event reporting system.

Journal: PloS one

Published: August 15, 2025

Efficacy of traditional Chinese medicine prescription in treatment of COVID-19: A prospective cohort study.

Efficacy of traditional Chinese medicine prescription in treatment of COVID-19: A prospective cohort study.

Journal: Medicine

Published: July 23, 2025

Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences.

Heterogeneity in adverse events associated with lumateperone: a study on potential subgroup-specific differences.

Journal: The international journal of neuropsychopharmacology

Published: July 13, 2025

Exploration of adverse event profiles for cefotaxime: a disproportionality analysis using the FDA adverse event reporting system.

Exploration of adverse event profiles for cefotaxime: a disproportionality analysis using the FDA adverse event reporting system.

Journal: BMC pharmacology & toxicology

Published: January 27, 2025

Randomized Trial of Pharmacist Integration in Haemodialysis Teams: Effects on Phosphorus Control and Patient Outcomes.

Randomized Trial of Pharmacist Integration in Haemodialysis Teams: Effects on Phosphorus Control and Patient Outcomes.

Journal: Blood purification

Published: January 24, 2025

Mining and analysis of adverse events associated with aducanumab: a real-world study using FDA Adverse Event Reporting System database.

Mining and analysis of adverse events associated with aducanumab: a real-world study using FDA Adverse Event Reporting System database.

Journal: Expert opinion on drug safety

Published: December 27, 2024

UPLC-MS metabolite profiling and antioxidant activity of Sanghuangporus sanghuang extract.

UPLC-MS metabolite profiling and antioxidant activity of Sanghuangporus sanghuang extract.

Journal: PeerJ

Published: July 24, 2024

Showing 1-12 of 27

Last Updated: 09/26/2026